|
FDA stamps approval on Eusa Pharma's orphan leukemia drug
FierceBiotech US regulators have given a market green light for Eusa Pharma's enzyme drug Erwinaze for a subset of patients with acute lymphoblastic leukemia who have immune reactions to an existing version of the therapy made with E. coli, the company said today. … |
More: continued here
